{"id":"AGY-FED-HEALTH-OTHER-007","kind":"order","level":"federal","jurisdiction":"United States (federal); Department of Justice, Drug Enforcement Administration","state":"","metro":"","industry":"","agency":"FED-HEALTH-OTHER","eco":"","issuer":"Drug Enforcement Administration (D. Christopher Evans, Acting Administrator)","authority":"21 U.S.C. 821, 822, 823, 871(b); 21 C.F.R. parts 1300, 1301, 1304","instrument":"Final Rule, Registration Requirements for Narcotic Treatment Programs With Mobile Components, 86 Fed. Reg. 33861 (June 28, 2021)","title":"Registration Requirements for Narcotic Treatment Programs With Mobile Components","dateIssued":"2021-06-28","effective":"2021-07-28","end":"In force (permanent)","startDate":"2021-07-28","endDate":"2021-09-30","quarters":["2021Q3"],"types":["HC","OTHER"],"addressees":["DEA-registered narcotic treatment programs"],"clause":"Under this final rule, an NTP is permitted to dispense narcotic drugs in schedules II-V from a mobile component at location(s) remote from, but within the same State as, the NTP\u0027s registered location, for the purpose of maintenance or detoxification treatment. Under this final rule, the NTP does not need to obtain a separate DEA registration for dispensing from the mobile component at a separate location as long as it complies with the requirements of the final rule.","enforcement":"Registration conditions under 21 U.S.C. 823-824; violations subject to 21 U.S.C. 842-843","functions":["CL clinical dispensing","TR transport","CB patients"],"notes":"Issued during and in response to the pandemic\u0027s disruption of in-person dosing; a Q3 2021 instrument changing how opioid treatment programs operated.","sourceUrl":"https://www.govinfo.gov/content/pkg/FR-2021-06-28/pdf/2021-13519.pdf","snapshot":"","fileExists":true,"fileBytes":459049,"grade":"primary","character":"","description":"","collection":"AGY-FED-HEALTH-OTHER","url":"/library/AGY-FED-HEALTH-OTHER-007","exhibitUrl":"/exhibit/AGY-FED-HEALTH-OTHER-007","citation":"Drug Enforcement Administration (D. Christopher Evans, Acting Administrator), Final Rule, Registration Requirements for Narcotic Treatment Programs With Mobile Components, 86 Fed. Reg. 33861 (June 28, 2021) (Ex. AGY-FED-HEALTH-OTHER-007)","stateName":"","related":[]}